Federal contract award
75N93022C00029
SBIR PHASE I
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $300.0K |
| Current contract value | $300.0K |
| Potential contract value / ceiling | $300.0K |
| Start date | Jul 1, 2022 |
| Current end date | Sep 30, 2025 |
| Potential end date | Sep 30, 2025 |
| Latest award activity | Jun 27, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 27, 2025 | P00006 | $0 | FY26 UDO INITIATIVE - SBIR PHASE I |
| Nov 7, 2024 | P00005 | $0 | SBIR PHASE I |
| Jun 10, 2024 | P00004 | $0 | SBIR PHASE I |
| Sep 22, 2023 | P00003 | $0 | SBIR PHASE I |
| Jan 17, 2023 | P00002 | $0 | SBIR PHASE I |
| Dec 21, 2022 | P00001 | $0 | IPP - PRECLINICAL EVALUATION OF HIV-1 ENVELOPE IMMUNOGENS IN HUMANIZED MICE |
| Jun 29, 2022 | 0 | $300.0K | SBIR PHASE I |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.